Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03
Recall Number: D-1143-2023
Firm: Esperion
Classification: Class III
Status: Terminated
Report Date: 20230913
Initiation Date: 20230816
Termination Date: 20260831
Reason for Recall
Failed dissolution specifications: below specification results at stability 12-month
Product Description
Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03